AI in Drug Development
A groundbreaking AI startup is revolutionizing drug development by significantly reducing the time and cost associated with clinical trials. By enhancing patient recruitment and predicting drug efficacy, toxicity, and tolerability, this technology allows companies to fail fast and focus resources on viable treatments. The conversation also touches on the potential for custom AI models that leverage scientific data to improve outcomes in both pharmaceuticals and other industries.In this clip
From this podcast
Equity
AI-powered drug development, VW teams up with Rivian, and DEI is 'bad'
Related Questions